Last reviewed · How we verify
NCT07250945: ADVA-PWS
AdvaTx Laser Treatment for Vascular Birthmarks
NA trial testing ADVATx laser treatment in Port-wine Stains (PWS) in 20 participants. Currently enrolling.
31 December 2026
Quick facts
| Lead sponsor | Szeged University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 10 December 2025 |
| Primary completion | 31 December 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across Hungary |
Drugs / interventions tested
- ADVATx laser treatment
Conditions studied
- Port-wine Stains (PWS) — all drugs for Port-wine Stains (PWS) →
- Vascular Birthmark — all drugs for Vascular Birthmark →
Sponsor
Szeged University
Who can join
Adults 7 to 65, any sex, with Port-wine Stains (PWS) or Vascular Birthmark. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of the present study is to get experiences with the use of CE-marked ADVATx laser treatment for port-wine stains. Secondary objectives: To investigate the clinical efficacy of ADVATx laser treatment for port-wine stains. To investigate the potential side effects (erythema, hyperpigmentation, oedema, pain, swelling, skin burning, blisters) of the treatment. Patients in the study will receive ADVATx laser treatment (1 treatment per month for 4 months) The treatment takes approximately 10-30 minutes per session. The treatment lasts for a total of 5 months for one patient. At each treatment session photographic documentation will be performed. PRO will be assessed by a questionnaire. At the end of the study, the patient rates the treatment and improvement on a Patient Satisfaction Scale.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07250945
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Szeged University trials
Trials by the same sponsor.
- NCT07250997 — PALLAS Laser for Skin Diseases · NA · recruiting
- NCT07523022 — Comparison of the Effect of Gonadotropin and Clomiphene Citrate Treatment on Sperm Parameters and the Outcome of Assiste · Phase 4 · enrolling by invitation
- NCT06933407 — Elastographic Assessment of Suburethral Tissue in Continent and Incontinent Women · recruiting
- NCT04966416 — Calcinosis Reduction by Pyrophosphate in SSC · NA · not yet recruiting
- NCT06247436 — Alternations in Body Composition of Tonsillectomy Patients During the Recovery Period · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07250945 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Szeged University
- Last refreshed: 6 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07250945.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing